The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of anti-VEGF receptor-3 (VEGFR-3) monoclonal antibody (mab) LY3022856/IMC-3C5 (3C5).
 
Wasif M. Saif
Honoraria - Celgene; Genentech; Sanofi
Speakers' Bureau - Novartis
Research Funding - Bayer; Celgene; Genentech; Halozyme; ImClone Systems; Lilly; Merck
 
James A. Knost
No Relationships to Disclose
 
E. Gabriela Chiorean
No Relationships to Disclose
 
Siva Rama Prasad Kambhampati
Employment - Lilly; Theorem Clinical Research (I)
Stock and Other Ownership Interests - Mannkind
 
Danni Yu
Employment - Lilly
 
Bronislaw Pytowski
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Amy Qin
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly (Inst)
 
John S. Kauh
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Lilly
 
Bert H. O'Neil
Consulting or Advisory Role - Acceleron Pharma; Amgen; Genentech/Roche; Lilly/ImClone; Sanofi
Speakers' Bureau - Amgen
Research Funding - Novartis (Inst)